In the Era of mRNA Vaccines, Is There Any Hope for HIV Functional Cure?
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 3, p. 501, doi. 10.3390/v13030501
- By:
- Publication type:
- Article
Works by Esteban, Ignasi
Results: 6
1
2
Author Correction: Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
3
Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-00838-8
- By:
- Publication type:
- Article
4
Assessment of Human SARS CoV-2-Specific T-Cell Responses Elicited In Vitro by New Computationally Designed mRNA Immunogens (COVARNA).
- Published in:
- Vaccines, 2024, v. 12, n. 1, p. 15, doi. 10.3390/vaccines12010015
- By:
- Publication type:
- Article
5
The Combination of an mRNA Immunogen, a TLR7 Agonist and a PD1 Blocking Agent Enhances In-Vitro HIV T-Cell Immune Responses.
- Published in:
- Vaccines, 2023, v. 11, n. 2, p. 286, doi. 10.3390/vaccines11020286
- By:
- Publication type:
- Article
6
Safety and immunogenicity of a recombinant protein RBD fusion heterodimer vaccine against SARS-CoV-2.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00736-5
- By:
- Publication type:
- Article